Go Pro

Hinge Health (HNGE) 10K Form and Latest SEC Filings 2026

Hinge Health logo
$88.86 +0.60 (+0.68%)
Closing price 09/11/2026 03:58 PM Eastern
Extended Trading
$88.66 -0.20 (-0.23%)
As of 09/11/2026 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Latest Hinge Health SEC Filings & Recent Activity

Hinge Health (NYSE:HNGE) has submitted 193+ documents to the U.S. Securities and Exchange Commission (SEC) since 2019. For investors, these filings are the primary source of verified financial data — covering everything from annual revenue and debt levels in the 10-K, to material business events in 8-K current reports, to insider buying and selling activity in Form 4 disclosures. Key figures from these filings, including revenue, earnings, and cash flow, are summarized in Hinge Health's financial statements. The most recent filing was a Form 4 submitted on September 11, 2026.

Form 4
Hinge Health, Inc. Reports Ownership Change on Sep. 11, 2026

Form 4 filings disclose changes in stock ownership by company insiders, including purchases, sales, grants, and option exercises.

View insider ownership

8-K
Hinge Health Files Current Report on Aug. 21, 2026

An 8-K is filed when a material corporate event occurs, such as an acquisition, leadership change, or financial update.

View filing

10-Q
Hinge Health Files Quarterly Report on May. 7, 2026

The 10-Q contains Hinge Health's unaudited quarterly financial statements, revenue, earnings updates, and cash flow changes between annual reports.

View earnings history

Hinge Health SEC Filing History

Browse Hinge Health's complete SEC filing history using the filters below. Filter by form type - 10-K, 10-Q, 8-K, Form 4, and more - or set a custom date range to find a filing.

DateFilerForm TypeView
09/11/2026 6:38 PM
Budge James (1338176) Reporting
Hinge Health (1673743) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2026 6:35 PM
Hinge Health (1673743) Issuer
Perez Daniel Antonio (2063236) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2026 5:50 PM
Hinge Health (1673743) Issuer
Robinson Elliott (2058536) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2026 3:30 PM
Hinge Health (1673743) Subject
Mecklenburg Gabriel M.I. (2062781) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/10/2026 3:44 PM
Budge James (1338176) Reporting
Hinge Health (1673743) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/09/2026 4:57 PM
Bessemer Venture Partners X L.P. (1768640) Reporting
Hinge Health (1673743) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/09/2026 4:58 PM
Bessemer Venture Partners X Institutional L.P. (1748910) Reporting
Hinge Health (1673743) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/09/2026 4:50 PM
Hinge Health (1673743) Issuer
Robinson Elliott (2058536) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2026 5:14 PM
Hinge Health (1673743) Issuer
Robinson Elliott (2058536) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
09/03/2026 3:08 PM
Hinge Health (1673743) Subject
Michael Triplett 2012 Irrevocable Trust. (1980707) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/01/2026 4:12 PM
Hinge Health (1673743) Subject
JL 2025 Family Trust LLC (2152243) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/01/2026 4:08 PM
Hinge Health (1673743) Subject
Jeffrey Lieberman 2012 Family Trust (2029414) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/01/2026 4:03 PM
Hinge Health (1673743) Subject
Lieberman Jeffrey (1328837) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/28/2026 5:06 PM
Hinge Health (1673743) Subject
Triplett Thomas Michael (1897385) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/27/2026 4:15 PM
Hinge Health (1673743) Issuer
Robinson Elliott (2058536) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
08/25/2026 4:17 PM
Bessemer Venture Partners X L.P. (1768640) Reporting
Hinge Health (1673743) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/25/2026 4:18 PM
Bessemer Venture Partners X Institutional L.P. (1748910) Reporting
Hinge Health (1673743) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/24/2026 4:31 PM
Hinge Health (1673743) Issuer
Pursley James (1783108) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
08/24/2026 4:32 PM
Budge James (1338176) Reporting
Hinge Health (1673743) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
08/21/2026 5:47 PM
Hinge Health (1673743) Issuer
Leslie Kristina M (1307207) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
08/21/2026 4:19 PM
Hinge Health (1673743) Issuer
Robinson Elliott (2058536) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
08/21/2026 3:26 PM
Hinge Health (1673743) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/20/2026 5:22 PM
Hinge Health (1673743) Subject
Leslie Kristina M (1307207) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/19/2026 3:33 PM
Bessemer Venture Partners X L.P. (1768640) Reporting
Hinge Health (1673743) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/19/2026 3:34 PM
Bessemer Venture Partners X Institutional L.P. (1748910) Reporting
Hinge Health (1673743) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/14/2026 5:53 PM
Hinge Health (1673743) Subject
Insight Holdings Group, LLC (1305473) Filed by
Form SCHEDULE 13G/A
08/14/2026 3:15 PM
Bessemer Venture Partners X L.P. (1768640) Filed by
Hinge Health (1673743) Subject
Form SCHEDULE 13G/A
08/12/2026 8:11 PM
Hinge Health (1673743) Issuer
Wardi Teddie Benjamin (1869541) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2026 3:39 PM
Hinge Health (1673743) Issuer
Mecklenburg Gabriel M.I. (2062781) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
08/04/2026 5:46 PM
Budge James (1338176) Reporting
Hinge Health (1673743) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
08/04/2026 5:48 PM
Hinge Health (1673743) Issuer
Pursley James (1783108) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
07/29/2026 8:06 PM
Hinge Health (1673743) Issuer
Perez Daniel Antonio (2063236) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
07/29/2026 8:07 PM
Hinge Health (1673743) Issuer
Mecklenburg Gabriel M.I. (2062781) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
07/09/2026 8:17 PM
Hinge Health (1673743) Issuer
Insight Holdings Group, LLC (1305473) Reporting
Insight Venture Associates X, L.P. (1844845) Reporting
Insight Venture Associates X, Ltd. (1803240) Reporting
Insight Venture Partners (0) Cayman
Insight Venture Partners X, L.P. (1710959) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
07/07/2026 6:46 PM
Hinge Health (1673743) Issuer
Sloat Tyler (1735436) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
07/07/2026 4:48 PM
Hinge Health (1673743) Subject
Insight Venture Partners X, L.P. (1710959) Reporting
Form 144/A
07/07/2026 3:37 PM
Hinge Health (1673743) Subject
Insight Venture Partners (0) Delaware
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/07/2026 3:46 PM
Hinge Health (1673743) Subject
Insight Venture Partners X (0) Co-Investors
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/07/2026 3:27 PM
Hinge Health (1673743) Subject
Insight Venture Partners X, L.P. (1710959) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/07/2026 3:14 PM
Hinge Health (1673743) Subject
Insight Venture Partners (0) Cayman
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/02/2026 3:35 PM
Hinge Health (1673743) Issuer
Mecklenburg Gabriel M.I. (2062781) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
The $15 Gold Fund That Pays Up to $1,152/Month (Ad)

Gold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying out up to $1,152 a month to regular investors - no mining stocks, no options, no physical metal required. Chief Income Strategist Tim Plaehn calls it a breakthrough strategy that transforms gold's rally into reliable monthly payouts. The next distribution is just days away.tc pixel

Discover the gold income fund before the next payout date
07/01/2026 3:51 PM
Hinge Health (1673743) Subject
Mecklenburg Gabriel M.I. (2062781) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/29/2026 8:25 PM
Hinge Health (1673743) Issuer
Insight Holdings Group, LLC (1305473) Reporting
Insight Venture Associates X, L.P. (1844845) Reporting
Insight Venture Associates X, Ltd. (1803240) Reporting
Insight Venture Partners (0) Cayman
Insight Venture Partners X, L.P. (1710959) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
06/29/2026 8:27 PM
Hinge Health (1673743) Issuer
Insight Holdings Group, LLC (1305473) Reporting
Insight Venture Associates X, L.P. (1844845) Reporting
Insight Venture Associates X, Ltd. (1803240) Reporting
Insight Venture Partners (0) Cayman
Insight Venture Partners X, L.P. (1710959) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
06/29/2026 4:24 PM
Hinge Health (1673743) Subject
Insight Venture Partners X (0) Co-Investors
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/29/2026 4:20 PM
Hinge Health (1673743) Subject
Insight Venture Partners (0) Delaware
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/29/2026 3:55 PM
Hinge Health (1673743) Subject
Insight Venture Partners X, L.P. (1710959) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/29/2026 3:47 PM
Hinge Health (1673743) Subject
Insight Venture Partners (0) Cayman
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/24/2026 8:56 PM
Hinge Health (1673743) Issuer
Insight Holdings Group, LLC (1305473) Reporting
Insight Venture Associates X, L.P. (1844845) Reporting
Insight Venture Associates X, Ltd. (1803240) Reporting
Insight Venture Partners (0) Cayman
Insight Venture Partners X, L.P. (1710959) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2026 8:57 PM
Hinge Health (1673743) Issuer
Insight Holdings Group, LLC (1305473) Reporting
Insight Venture Associates X, L.P. (1844845) Reporting
Insight Venture Associates X, Ltd. (1803240) Reporting
Insight Venture Partners (0) Cayman
Insight Venture Partners X, L.P. (1710959) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2026 3:52 PM
Hinge Health (1673743) Issuer
Pursley James (1783108) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2026 8:52 PM
Hinge Health (1673743) Issuer
Insight Holdings Group, LLC (1305473) Reporting
Insight Venture Associates X, L.P. (1844845) Reporting
Insight Venture Associates X, Ltd. (1803240) Reporting
Insight Venture Partners (0) Cayman
Insight Venture Partners X, L.P. (1710959) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2026 4:38 PM
Hinge Health (1673743) Subject
Insight Venture Partners X, L.P. (1710959) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/16/2026 4:24 PM
Hinge Health (1673743) Subject
Insight Venture Partners (0) Cayman
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/16/2026 4:29 PM
Hinge Health (1673743) Subject
Insight Venture Partners (0) Delaware
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/16/2026 4:18 PM
Hinge Health (1673743) Subject
Insight Venture Partners X (0) Co-Investors
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/12/2026 3:18 PM
Hinge Health (1673743) Issuer
Robinson Elliott (2058536) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
06/09/2026 3:06 PM
Hinge Health (1673743) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/08/2026 3:02 PM
Atomico Advisors IV, Ltd. (2069654) Filed by
Hinge Health (1673743) Subject
Form SCHEDULE 13G/A
06/05/2026 7:16 PM
Hinge Health (1673743) Issuer
Mecklenburg Gabriel M.I. (2062781) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2026 5:51 PM
Hinge Health (1673743) Issuer
Leslie Kristina M (1307207) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2026 3:19 PM
Hinge Health (1673743) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/03/2026 4:31 PM
Hinge Health (1673743) Issuer
Robinson Elliott (2058536) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
06/01/2026 6:10 PM
Hinge Health (1673743) Issuer
Pursley James (1783108) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
06/01/2026 6:13 PM
Budge James (1338176) Reporting
Hinge Health (1673743) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
06/01/2026 3:15 PM
Bessemer Venture Partners X Institutional L.P. (1748910) Reporting
Hinge Health (1673743) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/27/2026 6:08 PM
Hinge Health (1673743) Issuer
Mecklenburg Gabriel M.I. (2062781) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
05/27/2026 6:14 PM
Hinge Health (1673743) Issuer
Pursley James (1783108) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
05/27/2026 6:16 PM
Budge James (1338176) Reporting
Hinge Health (1673743) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
05/26/2026 3:45 PM
Budge James (1338176) Reporting
Hinge Health (1673743) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/21/2026 3:36 PM
Budge James (1338176) Reporting
Hinge Health (1673743) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2026 3:36 PM
Budge James (1338176) Reporting
Hinge Health (1673743) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/19/2026 8:18 PM
Budge James (1338176) Reporting
Hinge Health (1673743) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2026 8:19 PM
Hinge Health (1673743) Issuer
Pursley James (1783108) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
05/11/2026 7:22 PM
Hinge Health (1673743) Issuer
Robinson Elliott (2058536) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
05/11/2026 3:33 PM
Budge James (1338176) Reporting
Hinge Health (1673743) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/07/2026 3:33 PM
Hinge Health (1673743) Filer
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/07/2026 3:18 PM
Bessemer Venture Partners X Institutional L.P. (1748910) Reporting
Hinge Health (1673743) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/06/2026 3:29 PM
Hinge Health (1673743) Subject
Perez Daniel Antonio (2063236) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/05/2026 3:06 PM
Hinge Health (1673743) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/04/2026 3:06 PM
Budge James (1338176) Reporting
Hinge Health (1673743) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
04/27/2026 6:26 AM
HANSAINVEST Hanseatische Investment-Limited Co (1633724) Filed by
Hinge Health (1673743) Subject
Form SCHEDULE 13G
04/22/2026 3:16 PM
Hinge Health (1673743) Issuer
Mecklenburg Gabriel M.I. (2062781) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
04/17/2026 7:13 AM
Hinge Health (1673743) Filer
Form DEFA14A
04/17/2026 7:17 AM
Hinge Health (1673743) Filer
Form ARS
04/17/2026 7:04 AM
Hinge Health (1673743) Filer
Form DEF 14A
04/07/2026 3:46 PM
Hinge Health (1673743) Issuer
Sloat Tyler (1735436) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2026 7:07 PM
Hinge Health (1673743) Issuer
Mecklenburg Gabriel M.I. (2062781) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2026 3:23 PM
Budge James (1338176) Reporting
Hinge Health (1673743) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2026 3:24 PM
Hinge Health (1673743) Issuer
Pursley James (1783108) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
03/27/2026 8:30 AM
Hinge Health (1673743) Subject
VANGUARD GROUP INC (102909) Filed by
Form SCHEDULE 13G/A
A letter from Shannon Stansberry (Ad)

Porter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down year in nearly two decades and total gains of almost 2,000% - his immediate reaction was disbelief. It took a trusted friend's personal vouching for Emmet Savage and a face-to-face trip to Ireland to change his mind. The full documentary, Investigating Project Prophet, is now live.tc pixel

Watch the full story and see the verified track record for yourself
03/24/2026 6:35 PM
Hinge Health (1673743) Issuer
Pursley James (1783108) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
03/24/2026 6:37 PM
Budge James (1338176) Reporting
Hinge Health (1673743) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
03/23/2026 3:34 PM
Hinge Health (1673743) Subject
Pursley James (1783108) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/23/2026 3:35 PM
Budge James (1338176) Reporting
Hinge Health (1673743) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/10/2026 3:22 PM
Hinge Health (1673743) Issuer
Mecklenburg Gabriel M.I. (2062781) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
03/09/2026 7:50 PM
Atomico Advisors IV, Ltd. (2069654) Filed by
Hinge Health (1673743) Subject
Form SCHEDULE 13G/A
03/06/2026 3:32 PM
Hinge Health (1673743) Subject
Mecklenburg Gabriel M.I. (2062781) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/03/2026 4:25 PM
Budge James (1338176) Reporting
Hinge Health (1673743) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2026 6:12 PM
Hinge Health (1673743) Issuer
Robinson Elliott (2058536) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)

Hinge Health SEC Filings - Frequently Asked Questions

Hinge Health (HNGE) has submitted 193+ filings to the SEC since 2019. You can browse the complete history or filter by form type using the tools above.

Hinge Health's fiscal year ends on December 31. The company typically files its 10-K annual report by the end of February, covering the prior fiscal year's financial results. Key financial data from these reports is available on Hinge Health's financial statements page.

The most recent filing was a Form 4 submitted on September 11, 2026. This was an insider ownership change filed by 4 - Hinge Health, Inc. (0001673743) (Issuer).

SEC Filing Types: 10-K, 10-Q, 8-K and More

SEC filings are legally required disclosures that public companies submit to the U.S. Securities and Exchange Commission. Unlike press releases or earnings call transcripts, these documents are filed under legal obligation — meaning the financial data they contain is audited, standardized, and subject to penalties if materially false. For investors, that makes SEC filings the most reliable primary source available for evaluating a company's true financial position.

Yes. All SEC filings are publicly available through the SEC's EDGAR database and on financial research platforms like MarketBeat. Companies are required by law to make these disclosures accessible to all investors — meaning retail investors have access to the same source documents as institutional analysts.

A 10-K is an annual report containing audited financial statements and a full review of the company's business — it is the most comprehensive filing a company makes each year. A 10-Q is a shorter, unaudited quarterly update filed three times per year between annual reports. Investors typically use the 10-K for deep fundamental analysis and the 10-Q to track whether the company is on pace with its guidance mid-year.

The most important filing for fundamental investors. Filed once per year, the 10-K contains audited financial statements, revenue and earnings trends, debt obligations, risk factors, and management's own assessment of the business. Reading the risk factors section and comparing year-over-year financials can reveal issues that don't show up in analyst summaries.

An unaudited financial update filed three times per year (the 10-K covers Q4). Investors use 10-Qs to track whether guidance is on pace, monitor changes in cash flow or inventory, and catch any mid-year shifts in business conditions before they become headline news.

Filed within four business days of a material event — earnings releases, merger announcements, executive departures, or major asset sales. Because 8-Ks are filed before media coverage catches up, they are often the fastest way to get unfiltered information directly from the company on market-moving events.

Filed within two business days whenever an executive or director buys or sells company stock. Insider purchases — especially large or clustered buys — are often interpreted as a signal of management confidence. Insider selling is more ambiguous but worth monitoring for patterns, particularly around lock-up expirations or ahead of major announcements.


Related Companies and Tools


SEC filings for NYSE:HNGE are sourced directly from the U.S. Securities and Exchange Commission (SEC), with the most recent filing dated 9/11/2026. New filings are added as they're published.
From Our Partners